Vertex Pharmaceuticals Inc / Ma

UNITED CAPITAL FINANCIAL ADVISORS, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

12,077

Value ($000)

5,475

Weight

0.0%

2019 Q3 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	5,475	0.0%	12,077	12/31/2025
2025 Q3	11/14/2025	4,508	0.0%	11,512	9/30/2025
2025 Q2	8/11/2025	5,842	0.0%	13,122	6/30/2025
2025 Q1	5/13/2025	5,801	0.0%	11,966	3/31/2025
2024 Q4	2/13/2025	4,576	0.0%	11,364	12/31/2024
2024 Q3	11/12/2024	5,295	0.0%	11,385	9/30/2024
2024 Q2	8/14/2024	4,862	0.0%	10,372	6/30/2024
2024 Q1	5/15/2024	4,272	0.0%	10,221	3/31/2024
2023 Q4	2/14/2024	4,078	0.0%	10,022	12/31/2023
2023 Q3	11/14/2023	2,985	0.0%	8,585	9/30/2023
2023 Q2	8/14/2023	3,086	0.0%	8,770	6/30/2023
2023 Q1	8/15/2023	2,811	0.0%	8,922	3/31/2023
2022 Q4	2/15/2023	2,865	0.0%	9,920	12/31/2022
2022 Q3	11/14/2022	2,933	0.0%	10,131	9/30/2022
2022 Q2	8/11/2022	1,320	0.0%	4,685	6/30/2022
2022 Q1	5/16/2022	325	0.0%	1,246	3/31/2022
2021 Q4	2/14/2022	330	0.0%	1,502	12/31/2021
2021 Q3	11/15/2021	264	0.0%	1,454	9/30/2021
2021 Q2	8/13/2021	408	0.0%	2,024	6/30/2021
2021 Q1	5/14/2021	515	0.0%	2,395	3/31/2021
2020 Q4	2/17/2021	717	0.0%	3,035	12/31/2020
2020 Q3	11/13/2020	6,612	0.0%	24,299	9/30/2020
2020 Q2	8/13/2020	7,083	0.1%	24,397	6/30/2020
2020 Q1	8/11/2020	4,890	0.0%	20,551	3/31/2020
2019 Q4	2/14/2020	5,124	0.0%	23,404	12/31/2019
2019 Q3	2/14/2020	3,900	0.0%	23,020	9/30/2019